| Document |
Document Title |
|
JP2008297228A |
To provide a new production method of a 1,4-hydroquinone derivative with a condensed 1,3-dithiol ring.The production method of compounds (III) or (V) represented by general formulae (III) or (V), respectively, comprises causing a compoun...
|
|
JP4192578B2 |
Provided is a polymer having a polystyrene reduced number average molecular weight of 10 3 -10 8 , and comprising a repeating unit of formula (1): wherein A 1 is a divalent group represented by -Z- or -Z-Z-, in which Z is an atomic group...
|
|
JP4194715B2 |
|
|
JP4195074B2 |
[Object] To provide a substituted cycloalkene derivative having an action to supress intracellular signal transduction or cell activation induced by endotoxin and to suppress cell responses due to the intracellular signal transduction an...
|
|
JP4193222B2 |
|
|
JP2008543743A |
The invention features dental compositions comprising at least one hybrid monomer that comprises a cyclic allylic sulfide moiety attached to a (meth)acryloyl moiety. These two functional moieties are typically joined either directly to e...
|
|
JP2008540465A |
The invention relates to derivatives of dihydroxyphenylalanine, to their synthesis and to pharmaceutical compositions containing said derivatives of dihydroxyphenylalanine. Furthermore, the invention relates to the use of said derivative...
|
|
JP2008260760A |
To provide a pharmaceutical composition excellent in prevention and/or therapy of diseases such as septicemia, a compound able to be used for the same and a method for producing the same.The pharmaceutical composition contains a compound...
|
|
JP2008255097A |
To provide a new compound utilized as an organic n-type semiconductor excellent in electron-transporting property.This fluorine-containing polycyclic aromatic compound expressed by general formula (I) [wherein, Ar1, Ar2 are each a 6C aro...
|
|
JP2008247849A |
To provide a radiation-curable composition providing a cured product having high refractive index and high Abbe's number.The sulfur-containing ethylenically unsaturated group-containing compound is obtained by reacting a sulfur-containin...
|
|
JP2008248172A |
To provide a radiation-curable composition which can be suitably used for producing a cured material capable of having a high refractive index and a high Abbe number.There are provided a sulfur-containing and ethylenically unsaturated gr...
|
|
JP4153302B2 |
A catalytic transfer hydrogenation process is provided. The catalyst employed in the process is a metal hydrocarbyl complex which is coordinated to defined bidentate ligands substituted with at least one group selected from an optionally...
|
|
JP4157107B2 |
Retinoids with retinoid receptor antagonistic activity, pharmaceutically acceptable salts and pharmaceutically acceptable hydrolyzable esters thereof, have been found efficacious in treating T-helper cell type 2 (Th2)-mediated immune dis...
|
|
JP4156367B2 |
The invention relates to a process for the preparation of compounds containing at least one -CF2-O- bridge in the molecule, in which a) an acid is added onto at least one ketene dithioketal, b) the resultant bis(alkylthio)carbenium salt ...
|
|
JP4153031B2 |
The invention relates to compounds of the formulae:processes for their preparation, polymers, co-polymers or block co-polymers containing them or their use as monomers or co-monomers in free radical polymerisation and in the manufacture ...
|
|
JP2008195946A |
To provide a sulfur-containing polyurea-urethane and to provide a method for preparing the polyurea-urethane.In an embodiment, the sulfur-containing polyurea-urethane is adapted to have a refractive index of at least 1.57, an Abbe number...
|
|
JP2008531519A |
The invention relates to dithiolethiones derivatives as monoamino oxidase inhibitors, in particular MAO-B inhibitors, to methods for the preparation of these compounds and to novel intermediates useful for the synthesis of said dithiolet...
|
|
JP4132818B2 |
The invention relates to a process for the preparation of compounds having at least one -CF2O- bridge in the molecule, which comprises initially reacting a bis(alkylthio)carbenium salt with a compound containing at least one hydroxyl gro...
|
|
JP4132775B2 |
|
|
JP4130030B2 |
Disclosed is a 1,3-dihydro-1-oxo-2H-indene derivative having a specified structure, which may be used in a photosensitive composition.
|
|
JP2008528573A |
Compounds identified by the general formula (I) are used for the treatment of Alzheimer's disease
|
|
JP2008174453A |
To provide a new and useful therapeutic agent for scalp alopecia comprising lipoic acid or a lipoic acid derivative.The therapeutic agent for the scalp alopecia comprises the lipoic acid or the lipoic acid derivative such as a 6,8-dimerc...
|
|
JP4121380B2 |
|
|
JP2008156281A |
To provide a high purity crystalline salt of -lipoic acid and L-lysine, and an industrial method for preparing the same.The industrial method for preparing a high purity crystalline salt of -lipoic acid and L-lysine comprises gradually d...
|
|
JP2008156282A |
To provide a high purity salt of -lipoic acid and L-ornithine, and to provide a method for preparing the same.The method for preparing a high purity salt of -lipoic acid and L-ornithine comprises gradually dripping an aqueous ethanol sol...
|
|
JP4113680B2 |
To provide a new tetrathiafulvalene derivative into which aromatic ring(s) and thiol group(s) or disulfide group(s) are introduced so that the ring and group form a magnetic anisotropic unit. This tetrathiafulvalene derivative is express...
|
|
JP4115523B2 |
The present invention relates to novel bicyclic cyclopentane-1,3-dione derivatives of the formula (I)to a process for their preparation and to their use as pesticides and herbicides.
|
|
JP4109287B2 |
The present invention relates to a sulfur-containing polyureaurethane and a method of preparing said polyureaurethane. The sulfur-containing polyureaurethane is adapted to have a refractive index of at least 1.57,an Abbe number of at lea...
|
|
JP4102022B2 |
Compounds I-III wherein U is CH, O, or S; Z is mono- or di-substituted carbon; R is (CH2)nCO2H, (CH2)nSO3H, (CH2)nPO3H2, (CH2)nNO2, CH(SCH3)3, esters; R1 is H, hydroxyalkyl, aminoalkyl, alkoxyalkyl; RR1 is O; n is 0-4; R2, R3 is H, hydro...
|
|
JP4091111B2 |
Selected amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to such retroviral protease inhibitors and, more ...
|
|
JP2008516954A |
The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agent...
|
|
JP2008094781A |
To obtain an organic material suitable for application to an organic electronic device such as a transistor, an electric conversion element of sunlight, an electroluminescence element, etc., and a device.The tetrathiafulvalene derivative...
|
|
JP4078439B2 |
|
|
JP4073491B2 |
A family of compounds capable of inhibiting the activity of prenyl transferases. The compounds are covered by either of the two following formulas Each of the R groups is defined in the disclosure
|
|
JP2008506781A |
The present invention is directed to novel spiro-benzo[C]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the inven...
|
|
JP4056558B2 |
The invention relates to a diastereoselective process for the preparation of compounds of formula (1), wherein W is S, S=O, SO2 or O; X is S, S=O, SO2 or O; R1 is hydrogen or acyl, and R2 is a purine or pyrimidine base or an analogue or ...
|
|
JP4052943B2 |
A monomer containing an electron-withdrawing group of the present invention is represented by following Formula (a), (b) or (c): wherein A1, A2, and A3 are each a ring; Ra, Rb, Rc, and Ru are the same or different and are each a hydrogen...
|
|
JP2008024673A |
To provide a novel AGE (Advanced Glycation End Products) formation inhibitor useful as a preventive and/or therapeutic agent for glomerular diseases, especially a preventive and/or therapeutic medicine for diabetic nephropathy.The AGE fo...
|
|
JP2008007406A |
To provide a fat metabolism promoter containing a new ingredient metabolizing a fat as an active ingredient and to provide a fat metabolism promoter having a new ingredient promoting expression of enzyme gene of carnitine palmitoyltransf...
|
|
JP2007326863A |
To provide a compound useful as a retroviral protease inhibitor, and in particular as an inhibitor of HIV protease; and to provide a method for treating retroviral infection by the compound. The compound is represented by the chemical fo...
|
|
JP2007302573A |
To provide a dermatopathy-preventing agent that prevents, by peroral ingestion, dermatopathy such as skin ageing, pigmentation or the like caused by ultraviolet rays. The dermatopathy-preventing agent comprises α-lipoic acid and is oral...
|
|
JP4006030B2 |
|
|
JP2007531794A |
The present invention relates to a method of removing a silyl protecting group from an oligonucleotide, said method comprising the step of admixing the oligonucleotide with particular agents.
|
|
JPWO2005080322A1 |
The present invention relates to a novel fluorene derivative or a salt thereof, which is characterized by a structure in which a functional group such as a guanidino group is bonded to a fluorene skeleton via a carbonyl group. The compou...
|
|
JP3987964B2 |
Compositions containing conductivity enhancers, which are capable of being coated onto a substrate by means of electrostatic assistance. The compositions comprise one or more cationically polymerizable monomer(s), one or more cationic in...
|
|
JP3986796B2 |
|
|
JP3985020B2 |
An energy-sensitive (e.g., thermal, radiation or photosensitive) initiator, curative, and/or catalytic salt that has an anion comprising a tris-(highly fluorinated alkylsulfonyl)methide, tris-(fluorinated arylsulfonyl)methide, bis-(highl...
|
|
JP3981707B2 |
|
|
JP2007231020A |
To provide a new compound which improves the lipid barrier penetrability of a biologically active substance comprising a fatty acid such as lipoic acid and simultaneously makes a biologically active substance comprising a different fatty...
|
|
JP3969970B2 |
To obtain a hybrid compound which makes use of characteristic of a ferrocene compound to resolve a problem, imparts a reversible redox property to an organic site, and forms a redox system both in a metal site, i.e., iron atom and in the...
|
